Source:http://linkedlifedata.com/resource/pubmed/id/18451558
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2008-5-2
|
pubmed:abstractText |
We previously reported a quinoxalin-2-one compound (Compound 1) that had inhibitory activity equivalent to existing platelet-derived growth factor-beta receptor (PDGFbeta R) inhibitors. Lead optimization of Compound 1 to increase its activity and selectivity, using structural information regarding PDGFbeta R-ligand interactions, is urgently needed. Here we present models of the PDGFbeta R kinase domain complexed with quinoxalin-2-one derivatives. The models were constructed using comparative modeling, molecular dynamics (MD) and ligand docking. In particular, conformations derived from MD, and ligand binding site information presented by alpha-spheres in the pre-docking processing, allowed us to identify optimal protein structures for docking of target ligands. By carrying out molecular modeling and MD of PDGFbeta R in its inactive state, we obtained two structural models having good Compound 1 binding potentials. In order to distinguish the optimal candidate, we evaluated the structural activity relationships (SAR) between the ligand-binding free energies and inhibitory activity values (IC50 values) for available quinoxalin-2-one derivatives. Consequently, a final model with a high SAR was identified. This model included a molecular interaction between the hydrophobic pocket behind the ATP binding site and the substitution region of the quinoxalin-2-one derivatives. These findings should prove useful in lead optimization of quinoxalin-2-one derivatives as PDGFb R inhibitors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0009-2363
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
682-7
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18451558-Amino Acid Sequence,
pubmed-meshheading:18451558-Computer Simulation,
pubmed-meshheading:18451558-Drug Design,
pubmed-meshheading:18451558-Models, Molecular,
pubmed-meshheading:18451558-Molecular Sequence Data,
pubmed-meshheading:18451558-Muscle, Smooth, Vascular,
pubmed-meshheading:18451558-Phosphorylation,
pubmed-meshheading:18451558-Protein Binding,
pubmed-meshheading:18451558-Quinoxalines,
pubmed-meshheading:18451558-Receptor, Platelet-Derived Growth Factor beta,
pubmed-meshheading:18451558-Structure-Activity Relationship
|
pubmed:year |
2008
|
pubmed:articleTitle |
Structure activity relationships of quinoxalin-2-one derivatives as platelet-derived growth factor-beta receptor (PDGFbeta R) inhibitors, derived from molecular modeling.
|
pubmed:affiliation |
R & D Division, Tsumura & Co, Japan.
|
pubmed:publicationType |
Journal Article
|